Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes: a Double-blind Randomized Placebo-controlled Crossover Trial

NCT06376240 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT06376240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06376240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes: a Double-blind Randomized Placebo-controlled Crossover Trial
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 21, 2024
Completion date
March 13, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microvascular function, nephropathy, diabetic, neuropathy, diabetic, retinopathy, diabetic, type 2 diabetes